The global Coronary Stents Market the demand for portable and coronary stents will increase significantly over the next few years. Over the projection period, demand for coronary stents is anticipated to be driven by an ageing population and an increase in the prevalence of risk factors such cardiovascular diseases (CVDs), complicated lesions, diabetes, obesity, and others.
The rising awareness of benefits associated with stenting procedures such as significant improvement of blood flow and protection from further damage to the heart muscle contribute to the target market growth. Stenting also helps in improving the symptoms of heart disease, including angina and shortness of breath which, in turn, reduces the need for coronary bypass surgery. Hence, stenting is often preferred by surgeons as well as patients since it is a minimally invasive procedure and the post-operative recovery period is relatively short.
Sample of Research Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-1993
Furthermore, a rise in the global geriatric population is leading to a larger patient pool with serious cardiovascular diseases. Again, hypertension is arising as a grave public health concern. Obesity, too, adds to this burden as one of the primary risk factors accountable for different cardiovascular diseases worldwide.
Coronary stenting is prescribed to patients who are suffering from coronary artery blockage. Though angioplasty is the first line of treatment for patients with acute coronary artery blockages while the number of patients undergoing stenting has been increasing steadily over the last ten years. This is owing to the rise of outpatient coronary stenting procedures, which shortens long hospital stays. Additionally, a large number of cardiologists prescribing stenting procedures for patients with CAD is a prime factor that will likely fuel revenue growth of the coronary stent market during the forecast period.
“Increasing cases of lifestyle diseases like obesity and diabetes often result in heart issues which, in turn, supplements the global growth of the coronary stents market over the forecast period,” says an FMI analyst.
Cardiac stents have revolutionized the treatment of coronary artery disease, allowing many patients to avoid more invasive procedures such as coronary artery bypass surgery. However, they do carry some risks, such as blood clots forming in or around the stent, and they require lifelong treatment with antiplatelet medications to prevent clotting. It is important for patients with coronary stents to follow their doctor’s instructions carefully and attend regular follow-up appointments to monitor the stent and ensure it is functioning properly.
Key Takeaways:
- Rising awareness of the benefits associated with stenting will strengthen market prospects.
- Prevalence of alternative treatment methods, product failure, and recalls are certain factors that may hamper market growth.
- Growing cases of coronary artery diseases propel the coronary stent market in the United States.
- Favorable government support for the healthcare sector will present new market opportunities in China.
Inquire Before Buying Research Report @
https://www.futuremarketinsights.com/ask-question/rep-gb-1993
Competitive Landscape
Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific Corporation, C. R. Bard, Inc., and Cook Medica among others are some of the major players in the coronary stents market profiled in the full version of the report.
Key market players are focusing on product upgradation and offering new features to meet the rising consumer demand. These organizations are employing strategies like new product releases, partnerships, collaborations, mergers, and acquisitions to gain a competitive advantage.
More Insights into Coronary Stents Market Report
In its latest report, FMI offers an unbiased analysis of the global coronary stents market, providing historical data from 2016 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of product type (drug eluting stent (DES), bare metal stent (BMS), bioresorbable vascular stent (BVS)), raw material (cobalt chromium, stainless steel, platinum-chromium, nickel-titanium, polymer), end user (hospitals, ambulatory surgical centers, cardiac catheterization laboratories), and region.
According to the latest FMI reports, based on region, China’s coronary stent market will likely exhibit an impressive growth rate during the observation period due to favorable government support for the healthcare sector. The coronary stent market in the United States is anticipated to demonstrate substantial growth over the forecast period. The rising prevalence of coronary artery disease is spurring the demand for interventional cardiology treatment in this country. Sedentary lifestyles, smoking, poor dietary habits, and pollution often contribute to increasing cases of cardiovascular diseases. All of these factors are expected to drive the demand for the target market during 2022-2032.
Request Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-1993
Key Companies Profiled:
- Abbott
- Medtronic
- Boston Scientific Corporation
- Terumo Corporation
- B Braun Melsungen AG
- Biotronik
- Stentys SA
- MicroPort Scientific Corporation
- C. R. Bard, Inc.
- Cook Medical
Key Segments Covered in the Coronary Stents Industry Analysis
By Product:
- Drug Eluting Stent (DES)
- Bare Metal Stent (BMS)
- Bioresorbable Vascular Stent (BVS)
By Raw Material:
- Cobalt Chromium
- Stainless Steel
- Platinum – Chromium
- Nickel – Titanium
- Polymer
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
About Us
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs
